UBS Initiates Coverage of Veritone With Neutral Rating

According to UBS research released June 1, UBS initiated coverage of Veritone Inc (NASDAQ: VERI) with a Neutral rating and a $2.50 price target. Per the same UBS report, the bank models a 25% total revenue compound annual growth rate for Veritone spanning 2025-2028. UBS identifies the Veritone Data Refinery (VDR), launched in 2024, as a capability that helps convert unstructured text, video, and audio into training data for AI models, and cites a forecasted training-data market expanding from $2.6 billion in 2024 to $17 billion by 2032.

Insider Monkey and a Yahoo Finance republish note that Veritone shares have declined roughly 25% over the past month and report that about 19 hedge funds hold stakes in the company. Investing.com snapshots place the share price near $2.12 at the time of reporting. UBS research disclosures available on its site also state that UBS has provided investment banking services to the issuer, makes a market in the security, and has received compensation, per the UBS disclosure page.

Editorial analysis - technical context: The firm-level detail about VDR in UBS research frames it as a data refinement and labeling pipeline aimed at preparing multimodal datasets for model training. In the broader data pipeline market, products that transform audio, video, and text into model-ready datasets typically combine automated metadata extraction, human-in-the-loop annotation, and quality assurance. These capabilities are the core value propositions buyers seek when procuring training-data services.

Analyst initiation of coverage with a Neutral rating and a modest price target is primarily an investor signal rather than a technical endorsement. For practitioners, the notable elements in UBS research are the emphasis on a growing training-data market and the explicit modeling of revenue growth. Companies that compete in training-data and data-refinement services often face unit-economics pressure until they scale, driven by annotation labor, tooling investment, and the cadence of enterprise procurement cycles.

For observers tracking Veritone or similar providers, the following indicators will be informative: reported VDR deal sizes and contract durations; disclosed gross margins on data services versus software; new named customers in media, government, or legal sectors; cadence of repeat business for annotation pipelines; and any updates to UBS coverage or consensus estimates from other brokerages. Also monitor filings or press releases for material partnerships that explicitly tie VDR outputs to model training projects.

Editorial analysis: UBS disclosure of investment banking relationships and market-making activity is a standard reminder to weigh potential conflicts when interpreting research conclusions. Independent verification of commercial traction, through customer case studies or audited revenue disclosures, remains the most direct way to validate addressable-market claims cited in sell-side research.

UBS has started formal coverage of Veritone and frames VDR as the strategic product for the company to capture a slice of a growing training-data market. Reported near-term growth assumptions and the price target are explicit in UBS research; outside publishers report the recent share-price pullback and hedge fund ownership. Industry observers and practitioners should treat UBS projections as one input and watch for concrete revenue and contract disclosures to confirm commercial momentum.